Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,207.38
    +2,915.00 (+6.16%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

European shares gain, Generali up on dividend commitment

By Atul Prakash

LONDON, May 27 (Reuters) - European shares rose on Wednesday after sharp declines in the previous session, with Italy's biggest insurer Generali (Swiss: ASG.SW - news) gaining after committing to boost dividends and enzymes maker Novozymes (Other OTC: NVZMF - news) advancing on a UBS upgrade.

Shares (Berlin: DI6.BE - news) in Generali progressed by 2 percent after the company said it would pay cumulative dividends of more than 5 billion euros ($5.5 billion) to the end of 2018, as it focuses on increasing cash generation and building a solid capital base.

Novozymes, the world's largest maker of industrial enzymes, also rose 2.8 percent after UBS (NYSEArca: FBGX - news) raised its stance on the stock to "buy" from "sell".

ADVERTISEMENT

At 0711 GMT, the FTSEurofirst 300 index of top European shares was up 0.4 percent at 1,608.86 points after falling to a one-week low in the previous session.

Energy shares were also in demand, with the STOXX Europe 600 Oil and gas index rising 0.4 percent, as oil prices rebounded on expectations that U.S. crude stocks could fall for a fourth straight week. (Reporting by Atul Prakash; Editing by Sudip Kar-Gupta)